Corellia AI
Michael R. is currently the Chief Executive Officer at Corellia AI, a company Michael launched in 2023, leveraging their deep understanding of cancer biology gained during their time at Pfizer and Champions Oncology, Inc. Prior to this, Michael held various roles in business development and research in the oncology field. Michael holds a Ph.D. in Biochemistry from Temple University and an M.B.A. in Finance from NYU Stern School of Business.
This person is not in any teams
Corellia AI
Armed with an ever-growing understanding of cancer biology, Corellia AI was launched out of Champions Oncology, Inc. in 2023, leveraging Champions’ deep cancer dataset, rich suite of research platforms, and state-of-the-art experimental capabilities established over the past 15 years. Corellia AI has built a unique research ecosystem and partnered with world-leading biopharma and technology companies to execute our vision of building transformative first-in-class therapeutics.